The National Cancer Institute (NCI) is hoping to launch a $1.5 billion effort to identify all major mutations in the most common human cancers. The 10-year project would gather tumor samples from thousands of patients and scrutinize them for genetic glitches. "If we can sequence the cancer genome, … I think we must," says Anna Barker, NCI deputy director for strategic scientific initiatives.
No takes yet. Share an insight, caveat, or question.
Jocelyn Kaiser (2005) studied this question.